Breakthrough in siRNA-Based Therapy for Cancer Treatment

Strategic Insights -

Research conducted by scientists at Maharishi Markandeshwar (Deemed to be University) has led to a new understanding of siRNA-based therapy for cancer treatment. The study highlights the potential of nanoparticle-based drug delivery systems in effectively targeting cancer cells while overcoming resistance mechanisms. The research also emphasizes the adaptability of carriers based on smart drug delivery methods, utilizing nanoparticles as siRNA DDS to enhance physicochemical properties and overcome biological barriers.

Key Takeaways:

  • The research focuses on the use of nanoparticle-based drug delivery systems for cancer treatment, offering advantages such as greater stability, biocompatibility, and precise targeting capabilities.
  • Multifunctional nanoparticles have been designed to target cancer-related drug resistance mechanisms, including overexpression of drug efflux transporters, impaired apoptotic pathways, and hypoxic conditions.
  • Stimuli-responsive nanostructures have been developed to deliver natural chemicals in cancer therapy, reacting to both endogenous and external stimuli to manage effective dose loading, sustained release, and permeability.
  • The study emphasizes the potential of RNA interference (RNAi) as a therapeutic vehicle for the effective delivery of siRNA for cancer treatment.
  • Researchers at Maharishi Markandeshwar (Deemed to be University) have investigated the use of biodegradable nanoparticles for targeted delivery of therapeutics, highlighting their adaptability and potential for cancer treatment.

Statistics:

  • The study focuses on the development of "smart" drug delivery systems (DDS) that can effectively target cancer cells while overcoming resistance mechanisms.
  • The researchers utilized multifunctional nanoparticles to target cancer-related drug resistance mechanisms, including overexpression of drug efflux transporters.
  • The study highlights the potential of RNA interference (RNAi) as a therapeutic vehicle for the effective delivery of siRNA for cancer treatment.
  • Biodegradable nanoparticles were utilized for targeted delivery of therapeutics, presenting a characteristic suitable for diffused administration.

Sources:

  • Recent development in targeted gene silencing and cancer therapy by stimuli responsive multifunctional nanoparticles-based drug delivery system. Discover Applied Sciences, 2025,7(9):1-22. The publisher for Discover Applied Sciences is Springer.
  • A free version of this journal article is available at https://doi-org.sdpl.idm.oclc.org/10.1007/s42452-025-07455-7
  • Researchers at Maharishi Markandeshwar (Deemed to be University) provide information by contacting Manoj Singh, Department of Bio-Sciences and Technology, MMEC, Maharishi Markandeshwar (Deemed to be University)